Germline mutations in the BRCA1 or BRCA2 tumour-suppressor genes are strong predictors of breast and/or ovarian cancer development.

• 在BRCA1或BRCA2肿瘤抑制基因的种系突变是乳腺癌和/或卵巢癌进展的强烈预测指标。